PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportscandidemia
MeSH D058387 - candidemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D058365:Invasive candidiasis
1 Company
1 Drug
$
Success rate
D016469:Fungemia
33 Companies
2 Drugs
$
Success rate
D058387: 
Candidemia
22 Companies
4 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMicafungin Micafungin  2021-07-30   
MylanCaspofungin Caspofungin  2017-09-29   
CiplaCaspofungin Caspofungin  2018-07-12   
Merck & CoCaspofungin Cancidas  2001-01-26 $174 M Y2022 
Caspofungin Cancidas (previously Caspofungin MSD)  2001-10-23   
PfizerAnidulafungin Ecalta  2007-09-20   
Zydus TherapeuticsMicafungin Micafungin  2022-10-24   
ApotexMicafungin Micafungin  2020-11-05   
EndoMicafungin Micafungin  2021-06-16   
Accord HealthcareCaspofungin Caspofungin Accord  2016-02-11   
Astellas PharmaMicafungin Mycamine  2005-03-16   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
100%
6/6
Phase 3
47%
7/15
Approved: 3Overall Success rate: 47%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
Caspofungin
Pfizer
Anidulafungin,
Benzocaine,
Ademetionine,
Alfacalcidol,
Fk463
Astellas Pharma
Micafungin,
Antithrombin iii,
Fk463
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use